Stability-indicating micellar electrokinetic chromatography method for the analysis of sumatriptan succinate in pharmaceutical formulations

2011 ◽  
Vol 56 (5) ◽  
pp. 937-943 ◽  
Author(s):  
Khaldun M. Al Azzam ◽  
Bahruddin Saad ◽  
Chai Yuan Tat ◽  
Ishak Mat ◽  
Hassan Y. Aboul-Enein
Keyword(s):  
Micellar Electrokinetic Chromatography ◽  
Pharmaceutical Formulations ◽  
Electrokinetic Chromatography ◽  
Chromatography Method ◽  
Stability Indicating ◽  
Sumatriptan Succinate

Determination of dronedarone in the pharmaceutical dosage form by a stability-indicating micellar electrokinetic chromatography method

2013 ◽  
Vol 5 (12) ◽  
pp. 3106 ◽  
Author(s):  
Ana Isa Pedroso Marcolino ◽  
Maximiliano S. Sangoi ◽  
Martin Steppe ◽  
Andréa Inês Horn Adams ◽  
Clarice Madalena Bueno Rolim
Keyword(s):  
Dosage Form ◽  
Micellar Electrokinetic Chromatography ◽  
Electrokinetic Chromatography ◽  
Chromatography Method ◽  
Pharmaceutical Dosage Form ◽  
Stability Indicating

Development and validation of a stability-indicating micellar electrokinetic chromatography method to assay voriconazole tablets

2013 ◽  
Vol 5 (19) ◽  
pp. 5051
Author(s):  
Cristiane Franco Codevilla ◽  
Priscila Rosa ◽  
Martin Steppe ◽  
Ana Maria Bergold ◽  
Clarice Madalena Bueno Rolim ◽  
...  
Keyword(s):  
Micellar Electrokinetic Chromatography ◽  
Electrokinetic Chromatography ◽  
Chromatography Method ◽  
Stability Indicating ◽  
Development And Validation

A NOVEL STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL FORMULATIONS

INDIAN DRUGS ◽  
2017 ◽  
Vol 54 (08) ◽  
pp. 54-61
Author(s):  
B. Venkateswara Rao ◽  
◽  
S. Vidyadhara ◽  
V. Basaveswara Rao
Keyword(s):  
Method Development ◽  
Pharmaceutical Formulations ◽  
Hplc Method ◽  
Simultaneous Estimation ◽  
Uv Detector ◽  
Chromatography Method ◽  
Stability Indicating ◽  
Liquid Chromatography Method ◽  
Hplc Method Development ◽  
Development And Validation

The prime aim of the present investigation was to develop and validate a novel, precise, accurate, specific, rapid and economical stability- indicating isocratic reverse phase liquid chromatography method for the quantitative simultaneous estimation of valsartan and hydrochlorothiazide in bulk and marketed formulations. Estimation of drugs in this combination was achieved with a C18 column [Kromasil 100-5 C18 column, P134 250 × 4.6 mm] kept at ambient temperature, isocratic mode using mobile phase of composition acetonitrile and phosphate buffer (40:60 V/V, pH 4). The flow rate was 0.8 ml/min and the effluents were monitored at 235 nm, using variable wavelength UV detector. The retention time of valsartan and hydrochlorothiazide were 2.65 min and 3.97 min, respectively. Validation of the method was done according to the ICH guidelines for different analytical parameters. The method was found to be linear over a range of 50-250 μg/mL for valsartan and hydrochlorothiazide. The established method was as reproducible with a %RSD value of less than 2 and having robustness and accuracy within the specified limits. Assay of marketed formulation was determined and was 99.04% and 99.8% respectively. The stressed samples were analyzed. The proposed method was found to be specific and stability indicating as no interfering peaks of degradation compounds and excipients were noticed. The proposed method can be successfully employed in the estimation of commercial formulations.

Sign in / Sign up

Export Citation Format

Share Document